Report Update Nov 1, 2024

Russian Federation - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Russian Federation: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in the Russian Federation

For the third year in a row, the Russian medicaments containing insulin market recorded decline in sales value, which decreased by -69.8% to $X in 2021. Over the period under review, consumption showed a precipitous shrinkage. Over the period under review, the market hit record highs at $X in 2013; however, from 2014 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from the Russian Federation

In 2021, overseas shipments of medicaments containing insulin but not antibiotics decreased by -12.7% to X kg for the first time since 2018, thus ending a two-year rising trend. Over the period under review, exports, however, continue to indicate prominent growth. The pace of growth appeared the most rapid in 2020 when exports increased by 1,186% against the previous year. As a result, the exports reached the peak of X kg, and then shrank in the following year.

In value terms, medicaments containing insulin exports dropped to $X in 2021. Overall, exports, however, enjoyed a notable expansion. The most prominent rate of growth was recorded in 2020 when exports increased by 886%. Over the period under review, the exports hit record highs at $X in 2016; however, from 2017 to 2021, the exports failed to regain momentum.

Exports by Country

Turkmenistan (X kg) was the main destination for medicaments containing insulin exports from Russia, with a 72% share of total exports. Moreover, medicaments containing insulin exports to Turkmenistan exceeded the volume sent to the second major destination, Ukraine (X kg), fourfold. The third position in this ranking was held by Belarus (X kg), with a 5.3% share.

From 2012 to 2021, the average annual rate of growth in terms of volume to Turkmenistan amounted to +347.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: Ukraine (-11.5% per year) and Belarus (0.0% per year).

In value terms, Turkmenistan ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from Russia, comprising 63% of total exports. The second position in the ranking was taken by Ukraine ($X), with an 18% share of total exports. It was followed by Belarus, with a 15% share.

From 2012 to 2021, the average annual rate of growth in terms of value to Turkmenistan amounted to +342.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: Ukraine (+72.9% per year) and Belarus (0.0% per year).

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, leveling off at the previous year. In general, the export price, however, saw a pronounced slump. The pace of growth appeared the most rapid in 2015 an increase of 37% against the previous year. The export price peaked at $X per ton in 2016; however, from 2017 to 2021, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Belarus ($X per ton), while the average price for exports to Kazakhstan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Tajikistan (+272.3%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports into the Russian Federation

In 2021, medicaments containing insulin imports into Russia contracted significantly to X tons, with a decrease of -76.3% compared with the year before. Overall, imports continue to indicate a sharp downturn. The pace of growth appeared the most rapid in 2016 with an increase of 316%. Over the period under review, imports hit record highs at X tons in 2013; however, from 2014 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports fell markedly to $X in 2021. Over the period under review, imports recorded a sharp downturn. The pace of growth was the most pronounced in 2016 when imports increased by 302%. Over the period under review, imports reached the peak figure at $X in 2018; however, from 2019 to 2021, imports remained at a lower figure.

Imports by Country

In 2021, Germany (X tons) was the main supplier of medicaments containing insulin to Russia, with a approx. 100% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of volume from Germany amounted to -41.4%.

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Russia.

From 2012 to 2021, the average annual growth rate of value from Germany stood at -27.4%.

Import Prices by Country

In 2021, the average medicaments containing insulin import price amounted to $X per kg, increasing by 55% against the previous year. In general, the import price showed a significant increase. The pace of growth appeared the most rapid in 2020 an increase of 124% against the previous year. Over the period under review, average import prices hit record highs in 2021 and is likely to see gradual growth in the immediate term.

As there is only one major supplying country, the average price level is determined by prices for Germany.

From 2012 to 2021, the rate of growth in terms of prices for Germany amounted to +24.0% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

Denmark constituted the country with the largest volume of medicaments containing insulin consumption, accounting for 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin production was the U.S., comprising approx. 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to the Russian Federation?

In value terms, Germany constituted the largest supplier of medicaments containing insulin to Russia, comprising 96% of total imports. The second position in the ranking was occupied by India, with a 4.3% share of total imports.

What are the leading importers of medicaments containing insulin but not antibiotics from the Russian Federation?

It was followed by Ukraine, with a 4.9% share.

What is the average export price for medicaments containing insulin but not antibiotics in the Russian Federation?

In 2020, the average medicaments containing insulin export price amounted to $187,025 per ton, declining by -23.4% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in the Russian Federation?

In 2020, the average medicaments containing insulin import price amounted to $1,736 per kg, increasing by 10% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in the Russian Federation. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Russia

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in the Russian Federation
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023